Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Oral glucocorticoids: increased risk of mortality in patients with COPD

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Oral glucocorticoids: increased risk of mortality in patients with COPD. React. Wkly. 872, 4 (2001). https://doi.org/10.2165/00128415-200108720-00007

    Download citation

    Keywords

    • Chronic Obstructive Pulmonary Disease
    • Glucocorticoid
    • Prednisone
    • Chronic Obstructive Pulmonary Disease Patient
    • Rehabilitation Programme